SDC1 and neoplasm: Taken together, these results underline both the advantage of MSOT imaging in relation to NIRF imaging, i.e., deeper imaging depth as well as the great potential of this syndecan-1 tracer for combined MSOT/NIR imaging of a wide arrange of tumors, given the broad tumor expression of syndecan-1 [138].